Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

946
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
946
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PERK deficiency amplifies molecular, structural, and network vulnerability to repetitive mild traumatic brain injury.

Neurobiology of disease·2026
Same author

A multi-organ spatial metabolomic atlas of exercising mice reveals neuronal Complex I as a convergent and sufficient axis for tau pathology reduction in PS19.

bioRxiv : the preprint server for biology·2026
Same author

Circadian physiology changes with aging: age is just a number, but circadian physiology keeps time.

Current opinion in physiology·2026
Same author

The Biological Fate of DBS Leads After 15 Years of Stimulation.

Movement disorders clinical practice·2026
Same author

Hyperglycosylation is a metabolic driver of Alzheimer's disease.

Nature metabolism·2026
Same author

FBXL21 regulates diurnal proteostasis and stress response by targeting DNAJB6 and client proteins.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jul 2, 2025

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

9.0K

Targeted brain-specific tauopathy compromises peripheral skeletal muscle integrity and function.

Bryan Alava1,2, Gabriela Hery2, Silvana Sidhom1

  • 1Department of Physiology and Aging, University of Florida, Gainesville, FL 32610, USA.

Aging Brain
|February 29, 2024
PubMed
Summary

This study reveals that tauopathy, a neurodegenerative disease, causes skeletal muscle abnormalities and weakness. Pathological tau protein in neurons impacts muscle function, leading to reduced grip strength and contractile capacity.

More Related Videos

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.4K
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.4K

Related Experiment Videos

Last Updated: Jul 2, 2025

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

9.0K
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.4K
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

8.4K

Area of Science:

  • Neuroscience
  • Muscle Physiology

Background:

  • Tauopathies are neurodegenerative disorders characterized by tau protein aggregation and cognitive deficits.
  • Clinical observations suggest a link between tauopathy and muscle weakness, but the underlying mechanisms are unclear.

Purpose of the Study:

  • To investigate skeletal muscle abnormalities and contractile capacity in a mouse model of primary tauopathy.
  • To determine if neuronal pathological tau species contribute to peripheral muscle weakness.

Main Methods:

  • Utilized a mouse model expressing human mutant P301L-tau via adeno-associated virus serotype 8 (AAV8).
  • Assessed grip strength, hyperactivity, and performed histological analysis of skeletal muscle.
  • Conducted spatially resolved gene expression analysis of muscle cross-sections.
  • Measured specific force of the soleus muscle.

Main Results:

  • AAV8-P301L mice exhibited deficits in grip strength and hyperactivity.
  • Histological abnormalities and altered gene expression, particularly in sarcomeric proteins, were observed in skeletal muscle.
  • Specific muscle force was significantly reduced in male AAV8-P301L tau mice.

Conclusions:

  • Tauopathy leads to peripheral skeletal muscle dysfunction and weakness.
  • Neuronal tau pathology has direct consequences on muscle contractile capacity.
  • These findings highlight the systemic impact of tauopathies beyond the central nervous system.